Note: Ingredients listed on restricted chemical lists
EC/CAS
460-73-1
Name of the chemical
1,1,1,3,3-Pentafluoropropane
Concentration
N/A
EC/CAS
78-40-0
Name of the chemical
Phosphoric acid, triethyl ester, TEP
Concentration
N/A
EC/CAS
111-46-6
Name of the chemical
diethyleneglycol
Concentration
N/A
General Information
Revision date
2011-08-31
Product name
STYROFOAM(TM) SPF MX 2030 POLYOL 55gal
Icons in SDS
Company Information
company name
The Dow Chemical Company
GHS Information
Signal word
WARNING!
Section 2
SECTION 2: Hazards identification
OSHA Hazards Emergency Overview Color: Natural Physical State: Liquid. Odor: Amine. Hazards of product: WARNING! Causes eye irritation. May cause skin irritation. May be harmful if inhaled. Harmful if swallowed. Vapor reduces oxygen available for breathing. May cause anesthetic effects. May cause central nervous system effects; may cause respiratory tract irritation. Isolate area. Keep upwind of spill. OSHA Hazard Communication Standard This product is a "Hazardous Chemical" as defined by the OSHA Hazard Communication Standard, 29 CFR 1910.1200.
Potential health effects
Eye Contact: May cause severe eye irritation. May cause severe corneal injury. Vapor of amines may cause swelling of the cornea resulting in visual disturbances such as blurred or hazy vision. ®(TM)*Trademark Bright lights may appear to be surrounded by halos. Effects may be delayed and typically disappear spontaneously. Skin Contact: Prolonged contact may cause skin irritation with local redness. Skin Absorption: Prolonged skin contact is unlikely to result in absorption of harmful amounts. Massive contact with damaged skin or of material sufficiently hot to burn skin may result in absorption of potentially lethal amounts. Skin Sensitization For the minor component(s) Skin contact may cause an allergic skin reaction in a small proportion of individuals. Inhalation: Prolonged excessive exposure may cause adverse effects. In confined or poorly ventilated areas, vapor can easily accumulate and can cause unconsciousness and death due to displacement of oxygen. May cause respiratory irritation and central nervous system depression. Excessive exposure may increase sensitivity to epinephrine and increase myocardial irritability (irregular heartbeats). Symptoms of excessive exposure may be anesthetic or narcotic effects; dizziness and drowsiness may be observed. Ingestion: Ingestion of quantities (approximately 65 mL (2 oz.) for diethylene glycol or 100 mL (3 oz.) for ethylene glycol) has caused death in humans. Small amounts swallowed incidentally as a result of normal handling operations are not likely to cause injury; however, swallowing larger amounts may cause injury. The data presented are for the following material: Diethylene glycol. May cause nausea and vomiting. May cause abdominal discomfort or diarrhea. Excessive exposure may cause central nervous system effects, cardiopulmonary effects (metabolic acidosis), and kidney failure.
Aspiration hazard
Based on physical properties, not likely to be an aspiration hazard Effects of Repeated Exposure: Contains a component which is reported to be a weak organophosphate-type cholinesterase inhibitor. Excessive exposure may produce organophosphate type cholinesterase inhibition. Signs and symptoms of excessive exposure may be headache, dizziness, incoordination, muscle twitching, tremors, nausea, abdominal cramps, diarrhea, sweating, pinpoint pupils, blurred vision, salivation, tearing, tightness in chest, excessive urination, convulsions. Contains component(s) which have been reported to cause effects on the following organs in humans: Kidney. Contains component(s) which have been reported to cause effects on the following organs in animals: Liver. Respiratory tract. Heart.
Cancer information
For the minor component(s) Findings from a chronic skin painting study by NTP include liver tumors in mice. Mechanistic studies indicate that tumor formation is of questionable relevance to humans. Birth Defects/Developmental Effects: Diethylene glycol has caused toxicity to the fetus and some birth defects at maternally toxic, high doses in animals. Other animal studies have not reproduced birth defects even at much higher doses that caused severe maternal toxicity. Contains component(s) which did not cause birth defects in animals; other fetal effects occurred only at doses toxic to the mother. Reproductive Effects: Diethylene glycol did not interfere with reproduction in animal studies except at very high doses.